genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Neurons Grown in the Lab Strikingly Similar to Brain Cells
News
Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II…
News
CRISPR Aids Fight Against Neglected Tropical Diseases
News
Endocrine-Disrupting Chemical Found in Store Receipts
News
ALS Researchers Discover New Biomarker and Drug Target
Insights
Insights
Top 10 Global Biopharma IPOs of 2018
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
A-Lists
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Insights
Top 10 Molecular Millionaires of 2018
A-Lists
Top 10 Pharma Companies of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
News
Neurons Grown in the Lab Strikingly Similar to Brain Cells
News
Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II…
News
ALS Researchers Discover New Biomarker and Drug Target
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
Webinars
Streamlined Formulation of Enzyme Products
January 2019 Vol. 39 No. 1
American Association for the Advancement of Science
January 2019 Vol. 39 No. 1
Virtual Fly Brain
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Antibodies
Antibody Drug Conjugates
Antibody Drug Conjugates
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
Antibody Drug Conjugates
Catalent Invests $200M in Fast-Growing Biologics Manufacturing Business
Antibody Drug Conjugates
Bacterial Persister Cells Sleep with One Eye Open to Foil Immune Cells
Antibody Drug Conjugates
Pfizer Ends CytomX “Probody” Cancer Collaboration
Antibody Drug Conjugates
Magenta, Heidelberg Pharma Launch Bone Marrow Transplant ADC Collaboration
Antibody Drug Conjugates
Seattle Genetics, Pieris Launch Up-to-$1.2B Immuno-Oncology Collaboration
Antibody Drug Conjugates
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Antibody Drug Conjugates
Glythera, Iontas Launch Cancer ADC Collaboration
Antibody Drug Conjugates
Celgene Ends Option to Buy Sutro, Gains Rights to I/O Candidates...
Antibody Drug Conjugates
Astellas Shutting Agensys Research Operations, Axing 220 Employees in Retreat from...
Antibody Drug Conjugates
ADCT Exercises Option to License Chiome’s Anti-DLK-1 mAb for ADC Development
Antibody Drug Conjugates
Seattle Genetics Halts Enrollment in Vadastuximab Talirine Trials
Antibody Drug Conjugates
Glythera Wins Grant to Develop ADCs against Challenging Cancers
Antibody Drug Conjugates
BMS, Seattle Agree to Phase III HL Trial Combining Opdivo and...
Antibody Drug Conjugates
ImmunoGen Licenses Cancer Compounds to Sanofi
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
